APRICUS BIOSCIENCES INC Chart calendar Apricus Biosciences Inc
9ac90fb007cb0ef080.kbE8UQBDVkB-SAyRg1LxrxKW_5-9MXyrv1Go4BubDJ4.9uNZP0IiOgEIEUqj5GTc63qgzt3bVg3j9ySRq1fOQPXCgV5hQXA8K0cLNA~ddd458975eba767f24777d1b4d365764
Upcoming events on Apricus Biosciences Inc
Past events on Apricus Biosciences Inc
| 26/04/2024 | Q1 2024 Earnings Release (Projected) |
| 10/01/2024 06:30 pm | Extraordinary Shareholders Meeting |
| 13/11/2023 07:30 pm | Society for Neuroscience Meeting |
| 20/09/2023 05:30 pm | SLS-002 Phase II Study Results Call |
| 14/08/2023 | Q2 2023 Earnings Release |
| 18/07/2023 10:30 pm | Investor Meeting - Key Opinion Leader |
| 20/05/2023 12:30 am | American Society of Gene and Cell Therapy Meeting |
| 18/05/2023 | Annual General Meeting |
| 15/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 06/03/2023 | Cowen Health Care Conference |
| 23/02/2023 06:30 am | Alzheimer & Parkinson Drug Development Summit |
| 09/01/2023 | LifeSci Partners Corporate Access Conference |
| 15/12/2022 11:30 pm | Business Update Call |
| 16/11/2022 12:05 am | Guggenheim Immunology and Neurology Conference |
| 04/11/2022 03:15 am | Ataxia Research International Congress |
| 06/10/2022 | Cantor Neurology & Psychiatry Conference |
| 29/09/2022 12:15 am | Guggenheim Therapeutics Conference |
| 22/09/2022 | Jefferies Innovation in Mental Health Summit |
| 10/06/2022 09:00 pm | Jefferies Healthcare Conference |
| 20/05/2022 05:30 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,38 0,40 -6.25% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,20 1,55 42.13% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -29,7 -23,9 -24.29% | -18,8 -17,2 -8.93% | -61,7 -45,1 -36.76% | -70,9 -68,6 -3.33% | -40,5 -39,5 -2.56% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,3 -45,0 -13.84% | -19,1 -16,9 -12.83% | -66,0 -49,6 -33.16% | -73,5 -70,2 -4.71% | -37,9 -39,4 3.9% |
|
Net income Million USD | Released Forecast Spread | -51,3 -45,0 -13.84% | -19,1 -16,9 -12.83% | -66,0 -49,6 -33.16% | -73,5 -70,2 -4.71% | -37,9 -39,4 3.9% |
|
EPS USD | Released Forecast Spread | -75,6 -98,9 23.52% | -12,9 -11,4 -13.16% | -21,9 -16,6 -32.33% | -20,7 -18,9 -9.52% | -7,73 -0,41 -1785.37% |
| Announcement Date | 17/03/20 | 11/03/21 | 04/03/22 | 10/03/23 | 06/03/24 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,81 0,00 - | 0,34 0,00 - | 0,41 0,00 - | 0,65 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -27,4 -11,4 -139.15% | -14,0 -18,7 25.27% | -21,2 -15,4 -37.67% | -17,4 -12,5 -39.5% | -18,3 -16,0 -14.44% | -8,93 -13,3 32.81% | -11,0 -10,2 -7.09% | -12,6 -11,5 -9.22% | -8,01 -7,00 -14.44% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,3 -11,4 -138.49% | -14,0 -18,7 25.1% | -21,3 -15,4 -37.93% | -19,6 -12,5 -57.14% | -18,7 -16,0 -16.89% | -13,4 -13,2 -1.72% | -29,5 -10,3 -187.65% | 10,5 -11,5 191.12% | -5,45 -6,99 22.01% |
|
Net income Million USD | Released Forecast Spread | -27,3 -11,4 -138.49% | -14,0 -18,7 25.1% | -21,3 -15,4 -37.93% | -19,6 -12,5 -57.14% | -18,7 -16,0 -16.89% | -13,4 -13,2 -1.72% | -29,5 -10,3 -187.65% | 10,5 -11,5 191.12% | -5,45 -6,99 22.01% |
|
EPS USD | Released Forecast Spread | -8,40 -3,30 -154.55% | -3,90 -5,40 27.78% | -6,00 -4,30 -39.54% | -5,40 -3,40 -58.82% | -5,10 -3,90 -30.77% | -3,60 -3,20 -12.5% | -6,60 -2,85 -131.58% | 2,40 -1,80 233.33% | -0,80 |
| Announcement Date | 04/03/22 | 10/05/22 | 05/08/22 | 10/11/22 | 10/03/23 | 12/05/23 | 11/08/23 | 14/11/23 | 06/03/24 |
| 16/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:30 pm | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 24/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 25/07/2024 10:30 am | ARGENX SE: Q2 2024 Earnings Release |
| 30/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 31/07/2024 | CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected) |